QuidelOrtho Corporation (QDEL)
USD 26.2
(-7.62%)
USD 26.2
(-7.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.1 Million USD | -101.84% |
| 2022 | 548.7 Million USD | -22.08% |
| 2021 | 704.2 Million USD | -13.09% |
| 2020 | 810.28 Million USD | 1011.18% |
| 2019 | 72.92 Million USD | -1.7% |
| 2018 | 74.18 Million USD | 1008.55% |
| 2017 | -8.16 Million USD | 40.87% |
| 2016 | -13.8 Million USD | -127.14% |
| 2015 | -6.07 Million USD | 14.07% |
| 2014 | -7.07 Million USD | -195.72% |
| 2013 | 7.39 Million USD | 48.01% |
| 2012 | 4.99 Million USD | -34.59% |
| 2011 | 7.63 Million USD | 167.72% |
| 2010 | -11.27 Million USD | -134.28% |
| 2009 | 32.88 Million USD | 74.46% |
| 2008 | 18.84 Million USD | 38.27% |
| 2007 | 13.63 Million USD | -37.24% |
| 2006 | 21.71 Million USD | 334.56% |
| 2005 | -9.25 Million USD | -47.27% |
| 2004 | -6.28 Million USD | -131.99% |
| 2003 | 19.65 Million USD | 1422.15% |
| 2002 | 1.29 Million USD | 51.17% |
| 2001 | 854 Thousand USD | 114.61% |
| 2000 | -5.84 Million USD | 0.0% |
| 1998 | 7.7 Million USD | 600.0% |
| 1997 | 1.1 Million USD | -68.57% |
| 1996 | 3.5 Million USD | 483.33% |
| 1995 | 600 Thousand USD | 114.63% |
| 1994 | -4.1 Million USD | -105.0% |
| 1993 | -2 Million USD | -385.71% |
| 1992 | 700 Thousand USD | -12.5% |
| 1991 | 800 Thousand USD | 114.55% |
| 1990 | -5.5 Million USD | -358.33% |
| 1989 | -1.2 Million USD | 61.29% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.7 Billion USD | -24471.43% |
| 2024 Q2 | -147.7 Million USD | 91.34% |
| 2023 Q2 | -53.2 Million USD | -209.02% |
| 2023 Q1 | 48.8 Million USD | 61.06% |
| 2023 FY | -10.1 Million USD | -101.84% |
| 2023 Q3 | -12.7 Million USD | 76.13% |
| 2023 Q4 | 7 Million USD | 155.12% |
| 2022 FY | 548.7 Million USD | -22.08% |
| 2022 Q1 | 479.9 Million USD | 64.73% |
| 2022 Q2 | 19.3 Million USD | -95.98% |
| 2022 Q3 | 19.2 Million USD | -0.52% |
| 2022 Q4 | 30.3 Million USD | 57.81% |
| 2021 Q4 | 291.31 Million USD | 35.06% |
| 2021 FY | 704.2 Million USD | -13.09% |
| 2021 Q2 | 19.1 Million USD | -89.27% |
| 2021 Q3 | 215.7 Million USD | 1029.32% |
| 2021 Q1 | 178.08 Million USD | -62.12% |
| 2020 Q1 | 40.23 Million USD | 31.38% |
| 2020 Q4 | 470.13 Million USD | 102.41% |
| 2020 FY | 810.28 Million USD | 1011.18% |
| 2020 Q3 | 232.26 Million USD | 243.33% |
| 2020 Q2 | 67.65 Million USD | 68.13% |
| 2019 FY | 72.92 Million USD | -1.7% |
| 2019 Q2 | 1.27 Million USD | -94.89% |
| 2019 Q1 | 24.84 Million USD | -23.51% |
| 2019 Q4 | 30.62 Million USD | 89.27% |
| 2019 Q3 | 16.18 Million USD | 1174.09% |
| 2018 FY | 74.18 Million USD | 1008.55% |
| 2018 Q1 | 33.95 Million USD | 767.41% |
| 2018 Q3 | 10.82 Million USD | 451.82% |
| 2018 Q2 | -3.07 Million USD | -109.06% |
| 2018 Q4 | 32.47 Million USD | 200.12% |
| 2017 Q1 | 14.29 Million USD | 832.82% |
| 2017 FY | -8.16 Million USD | 40.87% |
| 2017 Q4 | -5.08 Million USD | 7.91% |
| 2017 Q3 | -5.52 Million USD | 53.34% |
| 2017 Q2 | -11.84 Million USD | -182.87% |
| 2016 Q3 | -572 Thousand USD | 92.7% |
| 2016 FY | -13.8 Million USD | -127.14% |
| 2016 Q4 | -1.95 Million USD | -240.91% |
| 2016 Q1 | -3.44 Million USD | -814.06% |
| 2016 Q2 | -7.84 Million USD | -127.51% |
| 2015 Q2 | -8.93 Million USD | -323.78% |
| 2015 FY | -6.07 Million USD | 14.07% |
| 2015 Q3 | -762 Thousand USD | 91.47% |
| 2015 Q1 | 3.99 Million USD | -43.89% |
| 2015 Q4 | -377 Thousand USD | 50.52% |
| 2014 Q4 | 7.11 Million USD | 223.34% |
| 2014 Q2 | -6.9 Million USD | -356.88% |
| 2014 Q1 | -1.51 Million USD | -232.75% |
| 2014 FY | -7.07 Million USD | -195.72% |
| 2014 Q3 | -5.76 Million USD | 16.52% |
| 2013 Q1 | 12.36 Million USD | 41.5% |
| 2013 Q3 | -4.36 Million USD | -148.49% |
| 2013 FY | 7.39 Million USD | 48.01% |
| 2013 Q4 | 1.13 Million USD | 126.12% |
| 2013 Q2 | -1.75 Million USD | -114.19% |
| 2012 Q3 | -676 Thousand USD | 78.35% |
| 2012 Q2 | -3.12 Million USD | -6221.57% |
| 2012 Q1 | 51 Thousand USD | -94.68% |
| 2012 FY | 4.99 Million USD | -34.59% |
| 2012 Q4 | 8.74 Million USD | 1392.9% |
| 2011 Q4 | 958 Thousand USD | 186.07% |
| 2011 Q1 | 11.44 Million USD | 2787.32% |
| 2011 FY | 7.63 Million USD | 167.72% |
| 2011 Q2 | -3.66 Million USD | -131.97% |
| 2011 Q3 | -1.11 Million USD | 69.59% |
| 2010 Q1 | -2.51 Million USD | -112.52% |
| 2010 Q4 | -426 Thousand USD | 92.73% |
| 2010 Q3 | -5.86 Million USD | -137.58% |
| 2010 Q2 | -2.46 Million USD | 1.99% |
| 2010 FY | -11.27 Million USD | -134.28% |
| 2009 Q4 | 20.1 Million USD | 34.59% |
| 2009 Q2 | 637 Thousand USD | 122.74% |
| 2009 Q1 | -2.8 Million USD | -146.14% |
| 2009 Q3 | 14.94 Million USD | 2245.37% |
| 2009 FY | 32.88 Million USD | 74.46% |
| 2008 Q1 | 8.55 Million USD | 5.48% |
| 2008 FY | 18.84 Million USD | 38.27% |
| 2008 Q4 | 6.07 Million USD | 28.03% |
| 2008 Q3 | 4.74 Million USD | 1024.17% |
| 2008 Q2 | -513 Thousand USD | -106.0% |
| 2007 FY | 13.63 Million USD | -37.24% |
| 2007 Q2 | -1.71 Million USD | -135.54% |
| 2007 Q4 | 8.1 Million USD | 234.96% |
| 2007 Q3 | 2.42 Million USD | 241.36% |
| 2007 Q1 | 4.81 Million USD | -73.67% |
| 2006 FY | 21.71 Million USD | 334.56% |
| 2006 Q4 | 18.29 Million USD | 753.76% |
| 2006 Q3 | 2.14 Million USD | 152.93% |
| 2006 Q2 | -4.04 Million USD | -175.99% |
| 2006 Q1 | 5.32 Million USD | -44.51% |
| 2005 Q1 | -17.85 Million USD | -2671.89% |
| 2005 Q4 | 9.6 Million USD | 1271.71% |
| 2005 Q3 | 700 Thousand USD | 140.94% |
| 2005 Q2 | -1.71 Million USD | 90.42% |
| 2005 FY | -9.25 Million USD | -47.27% |
| 2004 Q1 | 292 Thousand USD | -98.45% |
| 2004 FY | -6.28 Million USD | -131.99% |
| 2004 Q2 | -2.29 Million USD | -884.25% |
| 2004 Q3 | -3.64 Million USD | -59.17% |
| 2004 Q4 | -644 Thousand USD | 82.33% |
| 2003 Q3 | -481 Thousand USD | -31.06% |
| 2003 Q4 | 18.8 Million USD | 4010.4% |
| 2003 Q2 | -367 Thousand USD | -121.72% |
| 2003 Q1 | 1.69 Million USD | 198.59% |
| 2003 FY | 19.65 Million USD | 1422.15% |
| 2002 FY | 1.29 Million USD | 51.17% |
| 2002 Q4 | 566 Thousand USD | 147.6% |
| 2002 Q1 | 1.6 Million USD | 16.76% |
| 2002 Q2 | 305 Thousand USD | -81.04% |
| 2002 Q3 | -1.18 Million USD | -489.84% |
| 2001 Q3 | -75 Thousand USD | 91.34% |
| 2001 Q4 | 1.37 Million USD | 1937.33% |
| 2001 FY | 854 Thousand USD | 114.61% |
| 2001 Q1 | 417 Thousand USD | 116.37% |
| 2001 Q2 | -866 Thousand USD | -307.67% |
| 2000 Q3 | -4.54 Million USD | -5201.12% |
| 2000 Q4 | -2.54 Million USD | 43.9% |
| 2000 Q1 | 1.15 Million USD | 0.0% |
| 2000 FY | -5.84 Million USD | 0.0% |
| 2000 Q2 | 89 Thousand USD | -92.27% |
| 1999 Q2 | 500 Thousand USD | -93.33% |
| 1999 Q1 | 7.5 Million USD | 733.33% |
| 1999 Q3 | -2.4 Million USD | -580.0% |
| 1998 FY | 7.7 Million USD | 600.0% |
| 1998 Q1 | -100 Thousand USD | -105.88% |
| 1998 Q2 | - USD | 100.0% |
| 1998 Q4 | 900 Thousand USD | 228.57% |
| 1998 Q3 | -700 Thousand USD | 0.0% |
| 1997 Q2 | -800 Thousand USD | -161.54% |
| 1997 Q4 | 1.7 Million USD | 466.67% |
| 1997 FY | 1.1 Million USD | -68.57% |
| 1997 Q1 | 1.3 Million USD | -27.78% |
| 1997 Q3 | 300 Thousand USD | 137.5% |
| 1996 FY | 3.5 Million USD | 483.33% |
| 1996 Q4 | 1.8 Million USD | 800.0% |
| 1996 Q3 | 200 Thousand USD | 0.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1996 Q1 | 200 Thousand USD | -50.0% |
| 1995 Q1 | -2.4 Million USD | -442.86% |
| 1995 Q2 | - USD | 100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | 400 Thousand USD | 0.0% |
| 1995 FY | 600 Thousand USD | 114.63% |
| 1994 FY | -4.1 Million USD | -105.0% |
| 1994 Q4 | 700 Thousand USD | 200.0% |
| 1994 Q3 | -700 Thousand USD | 58.82% |
| 1994 Q2 | -1.7 Million USD | -70.0% |
| 1994 Q1 | -1 Million USD | -150.0% |
| 1993 Q1 | 500 Thousand USD | 66.67% |
| 1993 Q4 | -400 Thousand USD | 0.0% |
| 1993 FY | -2 Million USD | -385.71% |
| 1993 Q3 | - USD | 100.0% |
| 1993 Q2 | -600 Thousand USD | -220.0% |
| 1992 Q4 | 300 Thousand USD | 50.0% |
| 1992 Q1 | 400 Thousand USD | 33.33% |
| 1992 Q2 | -300 Thousand USD | -175.0% |
| 1992 Q3 | 200 Thousand USD | 166.67% |
| 1992 FY | 700 Thousand USD | -12.5% |
| 1991 Q4 | 300 Thousand USD | 200.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | 800 Thousand USD | 114.55% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | -5.5 Million USD | -358.33% |
| 1990 Q3 | - USD | 0.0% |
| 1989 FY | -1.2 Million USD | 61.29% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 84.05% |
| AngioDynamics, Inc. | -184.34 Million USD | 94.521% |
| AtriCure, Inc. | -30.43 Million USD | 66.818% |
| Avinger, Inc. | -18.32 Million USD | 44.869% |
| Azenta, Inc. | -14.25 Million USD | 29.158% |
| BioLife Solutions, Inc. | -66.42 Million USD | 84.795% |
| The Cooper Companies, Inc. | 294.2 Million USD | 103.433% |
| Daxor Corporation | 280.64 Thousand USD | 3698.917% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 33.544% |
| Femasys Inc. | -14.24 Million USD | 29.108% |
| GlucoTrack, Inc. | -7.09 Million USD | -42.314% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -195.754% |
| Hologic, Inc. | 789.5 Million USD | 101.279% |
| ICU Medical, Inc. | -29.65 Million USD | 65.942% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.562% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 26.498% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 133.549% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -51.574% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -51.574% |
| Masimo Corporation | 81.5 Million USD | 112.393% |
| Microbot Medical Inc. | -10.74 Million USD | 5.959% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 186.879% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 110.698% |
| Nephros, Inc. | -1.57 Million USD | -541.27% |
| NovoCure Limited | -207.04 Million USD | 95.122% |
| NEXGEL, Inc. | -3.15 Million USD | -219.924% |
| NEXGEL, Inc. | -3.15 Million USD | -219.924% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 89.348% |
| OraSure Technologies, Inc. | 53.65 Million USD | 118.824% |
| Pro-Dex, Inc. | 2.12 Million USD | 574.847% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 76.072% |
| Predictive Oncology Inc. | -13.98 Million USD | 27.774% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -242.213% |
| Repligen Corporation | 41.57 Million USD | 124.292% |
| Sanara MedTech Inc. | -4.3 Million USD | -134.709% |
| STAAR Surgical Company | 21.34 Million USD | 147.313% |
| Sharps Technology, Inc. | -9.84 Million USD | -2.625% |
| Utah Medical Products, Inc. | 16.63 Million USD | 160.715% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 92.348% |
| Jin Medical International Ltd. | 2.87 Million USD | 450.91% |